Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aplidin in Relapsed/Refractory Multiple Myeloma
NCT00229203Phase 2Completed
- Sponsor
- PharmaMar
- Start
- Feb 2005
- Primary completion
- Aug 2008
- Modality
- Cyclic Peptides, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of plitidepsin in multiple myeloma (MM), sponsored by PharmaMar. Started Feb 2005; status: completed.
02
Drugs
plitidepsin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00229203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00229203.